[1]
“Use of SGLT2 inhibitors in cardiovascular diseases: why, when and how? A narrative literature review”, Swiss Med Wkly, vol. 150, no. 3536, p. w20341, Sep. 2020, doi: 10.4414/smw.2020.20341.